Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 267,720 | 230,010 | 543,484 | 231,731 | 118,366 |
| Marketable Securities | 93,654 | 20,884 | 82,808 | 240,114 | 241,807 |
| Receivables | N/A | 33 | N/A | N/A | N/A |
| Inventories | 9,195 | 9,720 | N/A | N/A | N/A |
| TOTAL | $382,586 | $274,878 | $637,781 | $479,116 | $369,884 |
| Non-Current Assets | |||||
| PPE Net | 113,142 | 112,549 | 109,923 | 105,232 | 100,746 |
| Intangibles | 223,610 | 235,511 | 0 | 0 | 0 |
| Other Non-Current Assets | 132,977 | 134,355 | 77,063 | 79,634 | 75,294 |
| TOTAL | $469,729 | $482,415 | $186,986 | $184,866 | $176,040 |
| Total Assets | $852,315 | $757,293 | $824,767 | $663,982 | $545,924 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,274 | 31,157 | 31,572 | 26,603 | 24,255 |
| Accrued Expenses | 61,213 | 46,620 | 43,088 | 52,295 | 47,819 |
| TOTAL | $90,955 | $88,643 | $87,274 | $91,485 | $79,245 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Other Non-Current Liabilities | 68,009 | 68,844 | 69,612 | 71,859 | 71,943 |
| TOTAL | $87,352 | $90,081 | $70,612 | $72,859 | $72,943 |
| Total Liabilities | $178,307 | $178,724 | $157,886 | $164,344 | $152,188 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 255,918 | 247,777 | 224,449 | 224,239 | 157,841 |
| Common Shares | 11 | 9 | 9 | 8 | 7 |
| Retained earnings | -1,895,996 | -1,782,236 | -1,675,708 | -1,568,338 | -1,463,019 |
| Other shareholders' equity | -9,097 | 325 | -126 | -902 | -2,038 |
| TOTAL | $674,008 | $578,569 | $666,881 | $499,638 | $393,736 |
| Total Liabilities And Equity | $852,315 | $757,293 | $824,767 | $663,982 | $545,924 |